Arthrex ACP® double syringe

Trust the most researched product in the PRP / PRF industry with over 200 scientific studies.

Arthrex ACP® double syringe

Trust the most researched product in the PRP / PRF industry with over 200 scientific studies.

Fast, well tolerated, 100% endogenous substances

Liquid PRF / ACP for skin and hair

The ACP double syringe enables the closed and simple production of liquid PRF. No synthetic separating materials are used, as the liquid PRF is separated from the other blood components purely physically. This system, which has been used successfully for many years, enables the production of liquid PRF with an approximately 2.5-fold increase in platelet concentration with a simultaneous reduction in white blood cells and erythrocytes.

Natural Treatment

The body’s own regeneration

Documented Clinical Efficacy

(+200 clinical studies / FDA-Sanctioned Level-1 Study)

Intuitive Preparation

No separating gel and no anticoagulant required

Completely Autolog

No separating gel and no anticoagulant required

Innovative double chamber syringe

Closed system, made in Germany

Minimal Pain During Injection

The body’s own regeneration

Optimized Composition

Rich in fibrinogen, 2.5-fold platelet concentration, independently verified4,5

In just a few minutes without the addition of foreign substances

Simple, Fast, and Safe Production

Blood sampling

Centrifugation

PRP aspiration

The Treatment Process

User- and patient-friendly
    • Collection of a small amount of blood
    • Extraction of the body’s own active ingredients in concentrated form
    • Injection or application of these active ingredients into/to the area to be treated
    • Stimulation of hyaluronic acid and collagen synthesis, cell proliferation, and regeneration

The Mode of Action

Fast, well tolerated, 100% endogenous substances

Arthrex ACP therapy makes use of the body’s own processes: By injecting the body’s own liquid PRF at the site of action, the healing and regeneration of tissue can be stimulated in a purely natural way.

A large number of growth factors and proteins (including fibrinogen) found in thrombocytes and blood plasma are responsible for this. Interaction with corresponding receptors in the target cells, for example fibroblasts, mesenchymal stem cells and epidermal cells, initiates processes that lead to cell proliferation, hyaluronic acid and collagen synthesis, and matrix formation, among other things.

1

2

3

4

An Elegant System

Using the described method with the Arthrex ACP double syringe to prepare blood, the plasma contains a platelet concentration increased by about two to three times. Outside the bloodstream, platelets become activated and release proteins, for example, growth factors. These growth factors are known to be relevant for healing in a variety of tissue types and they appear to work synergistically.

BECOME A PROVIDER

If you are interested in administering the highest quality ACP services to your patients, contact the official distributor of Arthrex Personalized Cell Therapy in Southern Africa, NuAngle Medical by clicking on the button below.

References

1.Borzini P, Mazzucco L: Tissue Regeneration and in Loco Administration of Platelet Derivates: Clinical Outcomes, Heterogeneous Products, and Heterogeneity of Effector Mechanisms. Transfusion. 2005; 45: 1 759 – 1 767.
2. Edwards D et al: Transforming Growth Factor Beta Modulates the Expression of Collagenase and Metalloproteinase Inhibitor. The EMBO Journal. 1987; 6(7):
1 899 – 1 904.
3. Lynch S et al: Role of Platelet-derived Growth Factor in Wound Healing: Synergistic Effects with other Growth Factors. Proc. Natl. Acad. Sci. USA. 1987; 84:
7 696 – 7 700.
4. Graziani F et al: The In Vitro Effect of Different PRP Concentrations on Osteoblasts and Fibroblasts.
Clin Oral Implants Res. 2006; 17(2): 212 – 219.
5. Sundman E, Cole B, Fortier L: Growth Factor and Catabolic Cytokine Concentrations Are Influenced by the Cellular Composition of Platelet-Rich Plasma. American
Journal of Sports Medicine. 2011; 39(10): 2 135 – 2 140
6. Kisiday J et al: Effects of Platelet-Rich Plasma Composition on Anabolic and Catabolic Activities in Equine Cartilage
and Meniscal Explants. Cartilage. 2012; 3: 245 – 254
7. Mazzocca A et al: Platelet-rich plasma differs according to preparation method and human variability.
Journal of Bone & Joint Surgery. 2012; 94(4): 308 – 316
8. Mazzocca A et al: The positive effects of different platelet-rich plasma methods on human muscle, bone, and tendon cells.